HeartDrug Research LLC Report issue

For profit Phase 4
Founded: Towson MD United States (2007)
Status: Defunct (2015)

Organization Overview

First Clinical Trial
2009
NCT00819403
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

HeartDrug Research | President, HeartDrug Research LLC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 4)

Metabolic Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4